Literature DB >> 25686648

Prognostic role of peripheral blood lymphocyte/monocyte ratio at diagnosis in diffuse large B-cell lymphoma: a meta-analysis.

Baochai Lin1, Cuie Chen2, Yan Qian2, Jianhua Feng3.   

Abstract

To evaluate the prognostic value of the absolute lymphocyte count/absolute monocyte count ratio (ALC/AMC ratio) at diagnosis in diffuse large B-cell lymphoma (DLBCL), we performed a meta-analysis of published studies that provided survival information with reference to the ALC/AMC ratio at diagnosis. Nine studies covering a total of 4198 subjects were included in this analysis. The summary hazard ratios of low ALC/AMC ratio for overall survival were 2.00 (p = 0.000) in the population that received R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and 1.12 (p = 0.479) in the population that received CHOP. The corresponding ratios for event-free survival and progression-free survival were 1.93 (p = 0.000) and 2.31 (p = 0.000) in the population that received R-CHOP. These results may justify risk-adapted therapeutic strategies for patients with DLBCL treated with R-CHOP to account for the ALC/AMC ratio at diagnosis.

Entities:  

Keywords:  Diffuse large B-cell lymphoma; lymphocyte; meta-analysis; monocyte; prognosis

Mesh：

Substances：

Year:  2015        PMID： 25686648     DOI： 10.3109/10428194.2015.1014367

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


  14 in total

1.  The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.

Authors:  Jelena Jelicic; Milena Todorovic Balint; Maja Perunicic Jovanovic; Novica Boricic; Marjan Micev; Jelena Stojsic; Darko Antic; Bosko Andjelic; Jelena Bila; Bela Balint; Sonja Pavlovic; Biljana Mihaljevic
Journal:  Pathol Oncol Res       Date:  2016-01-11       Impact factor: 3.201

2.  Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.

Authors:  Theodoros P Vassilakopoulos; Maria N Dimopoulou; Maria K Angelopoulou; Kyriaki Petevi; Gerassimos A Pangalis; Maria Moschogiannis; Maria Dimou; George Boutsikas; Alexandros Kanellopoulos; Gabriella Gainaru; Eleni Plata; Pagona Flevari; Katerina Koutsi; Loula Papageorgiou; Vassilios Telonis; Panayiotis Tsaftaridis; Sotirios Sachanas; Xanthoula Yiakoumis; Pantelis Tsirkinidis; Nora-Athina Viniou; Marina P Siakantaris; Eleni Variami; Marie-Christine Kyrtsonis; John Meletis; Panayiotis Panayiotidis; Kostas Konstantopoulos
Journal:  Oncologist       Date:  2016-02-26

3.  The Lymphocyte-Monocyte Ratio and the Platelet-Lymphocyte Ratio at Diagnosis as Independent Prognostic Factors in Primary Gastrointestinal Diffuse Large B Cell Lymphoma.

Authors:  Pan Zhao; Li Zang; Xiaoying Zhang; Yafang Chen; Hongliang Yang; Haifeng Zhao; Yong Yu; Yafei Wang; Yizhuo Zhang; Xiaofang Wang
Journal:  Indian J Hematol Blood Transfus       Date:  2016-08-29       Impact factor: 0.900

4.  Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib.

Authors:  Yeonjung Ha; Mohamed A Mohamed Ali; Molly M Petersen; William S Harmsen; Terry M Therneau; Han Chu Lee; Baek-Yeol Ryoo; Sally Bampoh; Kenneth A Valles; Mohamad Mady; Venkata R Missula; Kritika Prasai; Lewis R Roberts; Kang Mo Kim
Journal:  Hepatol Int       Date:  2020-08-01       Impact factor: 6.047

5.  A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.

Authors:  Jun Cai; Xiaopeng Tian; Shuyun Ma; Liye Zhong; Wenyu Li; Liang Wang; Linlang Guo; Zhihua Li; Yudan Wu; Guangzheng Zhong; Huiqiang Huang; Zhongjun Xia; Yi Xia; Panpan Liu; Ning Su; Yu Fang; Yuchen Zhang; Qingqing Cai
Journal:  Br J Cancer       Date:  2021-05-19       Impact factor: 7.640

6.  Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Authors:  Yu-Mu Chen; Chien-Hao Lai; Huang-Chih Chang; Tung-Ying Chao; Chia-Cheng Tseng; Wen-Feng Fang; Chin-Chou Wang; Yu-Hsiu Chung; Yi-Hsi Wang; Mao-Chang Su; Kuo-Tung Huang; Hung-Chen Chen; Ya-Chun Chang; Meng-Chih Lin
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

7.  Prognostic significance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis.

Authors:  Wen-Kai Xia; Qing-Feng Lin; Dong Shen; Zhi-Li Liu; Jun Su; Wei-Dong Mao
Journal:  FEBS Open Bio       Date:  2016-05-04       Impact factor: 2.693

Review 8.  Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis.

Authors:  Liangyou Gu; Hongzhao Li; Luyao Chen; Xin Ma; Xintao Li; Yu Gao; Yu Zhang; Yongpeng Xie; Xu Zhang
Journal:  Oncotarget       Date:  2016-05-31

9.  Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports.

Authors:  Hui-Ling Sun; Yu-Qin Pan; Bang-Shun He; Zhen-Lin Nie; Kang Lin; Hong-Xin Peng; William C Cho; Shu-Kui Wang
Journal:  Onco Targets Ther       Date:  2016-05-20       Impact factor: 4.147

10.  Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.

Authors:  Xin Song; Gui-Ming Zhang; Xiao-Cheng Ma; Lei Luo; Bin Li; Dong-Yue Chai; Li-Jiang Sun
Journal:  Onco Targets Ther       Date:  2016-03-11       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.